Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Scopolamine on Ship Navigation Performance
NCT00374478Phase 2Completed
- Sponsor
- Boston University
- Start
- Apr 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of scopolamine in motion sickness, sponsored by Boston University. Started Apr 2005; status: completed.
02
Drugs
scopolamine
03
Conditions
motion sickness
Beyond the preview
Go deeper on NCT00374478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374478.